CZI's Biohub and Cellarity Partner to Develop Anti-Disease Cellular Machines
Mark Zuckerberg and Priscilla Chan, founders of the Chan Zuckerberg Initiative (CZI), announced plans to invest $250 million over 10 years to establish a new "biohub" in New York City focused on building cellular machines that can detect and treat diseases. The biohub will bring together researchers from Yale, Columbia, and Rockefeller to decode how immune cells sense and eliminate diseases like cancer and Alzheimer's. The long-term goal is to engineer cells that can detect and treat diseases before symptoms appear. The initiative is part of CZI's mission to cure, prevent, or manage all diseases by 2100.